Clinton M. Hasenour

Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance

Jeffrey S. Bonner, Louise Lantier, Clinton M. Hasenour et al. · Diabetes · 2012 · 107 citations · Full text

Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo

Eric D. Berglund, Li Kang, Robert S. Lee et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 97 citations · Full text

Fatty Liver Disease, Insulin Signaling, Metabolic Syndrome +27

Mass spectrometry-based microassay of²H and¹³C plasma glucose labeling to quantify liver metabolic fluxes in vivo

Clinton M. Hasenour, Martha L. Wall, D. Emerson Ridley et al. · American Journal of Physiology-Endocrinology and Metabolism · 2015 · 83 citations · Full text

5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo

Clinton M. Hasenour, D. Emerson Ridley, Curtis C. Hughey et al. · Journal of Biological Chemistry · 2014 · 67 citations · Full text

Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver

Eric D. Berglund, Daniel G. Lustig, Richard A. Baheza et al. · Diabetes · 2011 · 49 citations · Full text